[
    "{\"step_by_step_thinking\": \"To determine if Figitumumab is effective for non-small cell lung cancer, we need to review the available evidence. Figitumumab is a monoclonal antibody that targets the insulin-like growth factor 1 receptor (IGF-1R). Non-small cell lung cancer is a type of lung cancer that accounts for the majority of cases. To assess the effectiveness of Figitumumab, we need to consider clinical trials and studies that have evaluated its use in non-small cell lung cancer patients. Based on the available evidence, we can then determine if Figitumumab is effective or not.\", \"answer_choice\": \"B. no\"}"
]